𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pregabalin Add-on Treatment in Patients with Partial Seizures: A Novel Evaluation of Flexible-dose and Fixed-dose Treatment in a Double-blind, Placebo-controlled Study

✍ Scribed by Christian E. Elger; Martin J. Brodie; Henning Anhut; Caroline M. Lee; Jeannette A. Barrett

Book ID
109108552
Publisher
Wiley (Blackwell Publishing)
Year
2005
Tongue
English
Weight
149 KB
Volume
46
Category
Article
ISSN
0013-9580

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomised double-blind placebo-contro
A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures
✍ P. Loiseau; A.W.C. Yuen; B. DuchΓ©; T. MΓ©nager; M.C. ArnΓ©-BΓ¨s πŸ“‚ Article πŸ“… 1990 πŸ› Elsevier Science 🌐 English βš– 874 KB

Efficacy and safety of lamotrigine (LTG) as add-on therapy was assessed in a randomised double-blind placebo-controlled trial of this drug in 23 adult patients with refractory partial seizures. Fifteen patients showed an improvement on LTG treatment, with a greater than 50% decrease in total seizure

A double-blind, placebo-controlled evalu
A double-blind, placebo-controlled evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures
✍ T Rentmeester; A Janssen; J Hulsman; F Scholtes; B van der Kleij; J Overweg; J M πŸ“‚ Article πŸ“… 1991 πŸ› Elsevier Science 🌐 English βš– 655 KB

Sixty-two patients with uncontrolled partial seizures participated in a 12-week, double-blind, placebo-controlled add-on-trial. Thirty-two patients received loreclezole and 30 a placebo as add-on therapy. Loreclezole was targeted at a plasma level of 1-2 mg/l. In spite of an antiepileptic therapy, u